Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash Flows From Operating Activities
Net loss	$ (127,130)	$ (89,362)
Adjustment to reconcile net loss to net cash from operating activities:
Depreciation and amortization	232	261
Accrued financing on prepaid forward obligation	1,595	9,013
Accretion on marketable securities	(1,800)	(1,555)
Share-based compensation	8,829	9,805
Amortization (accretion) of discount on long-term debt	377	(1,330)
Amortization of right of use assets	1,500	619
Acquisitions of IPR&D	3,128	0
Changes in operating assets and liabilities:
Inventory	886	(1,921)
Accounts receivable, net	599	(7,359)
Prepaid expenses and other current assets	(3,277)	(3,772)
Other non-current assets	(6,170)	1,668
Accounts payable and accrued expenses	(1,258)	3,147
Employee related accrued expenses	544	(1,785)
Other current liabilities	(201)	0
Lease liabilities	(1,972)	(626)
Restricted deposit	(1)	50
Net cash used in operating activities	(124,119)	(83,147)
Cash Flows From Investing Activities
Purchases of marketable securities	(76,861)	(118,794)
Maturities of marketable securities	110,974	37,740
Purchases of property and equipment	(272)	(180)
Net cash provided by investing activities	33,841	(81,234)
Cash Flows From Financing Activities
Proceeds from exercise of options into ordinary shares	629	250
Proceeds from pre-funded warrant issuance, net of issuance costs	3	18,641
Proceeds from ordinary shares issuances, net of issuance costs	7,970	151,169
Net cash provided by financing activities	8,602	194,548
Increase (Decrease) in Cash and Cash Equivalents	(81,676)	30,167
Cash, Cash Equivalents and Restricted Cash at Beginning of Period	173,062	95,822
Cash, Cash Equivalents and Restricted Cash at End of Period	91,386	125,989
Proceeds from issuance of long-term debt	0	24,488
Supplemental Disclosures of Non-Cash Activities
Right of use assets obtained in exchange for new operating lease liabilities	6,856	0
Acquisitions of IPR&D	$ 3,128	$ 0